MIR133A regulates cell proliferation, migration, and apoptosis by targeting SOX9 in human colorectal cancer cells
Related Experiment Video
Updated: Sep 1, 2025

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
Published on: January 22, 2021
Santosh Lamichhane1, Ji-Su Mo2, Grinsun Sharma1
1Department of Pathology, School of Medicine, Wonkwang University Iksan, Chonbuk 54538, Korea.
Abstract:
The human microRNA 133A (MIR133A) was identified as a CRC-associated miRNA. It was down-regulated in human CRC tissues. We identified the putative MIR133A1 and A2 target genes by comparing the transcriptome analysis data of MIR133A1 and A2 knock-in cells with the candidate MIR133A target genes predicted by bioinformatics tools. We identified 29 and 33 putative MIR133A and A2 direct target genes, respectively. Among them, we focused on the master transcription regulator gene SRY-box transcription factor 9 (SOX9), which exhibits a pleiotropic role in cancer. We confirmed that SOX9 is a direct target gene of MIR133A by luciferase reporter assay, quantitative RT-PCR, and western blot analysis. Overexpression of MIR133A in CRC cell lines significantly decreased SOX9 and its downstream PIK3CA-AKT1-GSK3B-CTNNB1 and KRAS-BRAF-MAP2K1-MAPK1/3 pathways and increased apoptosis. Furthermore, functional studies reveal that cell proliferation, colony formation, and migration ability were significantly decreased by MIR133A-overexpressed CRC cell lines. Knockdown of SOX9 in CRC cell lines by SOX9 gene silencing showed similar results. We also used a xenograft model to show that MIR133A overexpression suppresses tumor growth and proliferation. Our results suggest that MIR133A regulates cell proliferation, migration, and apoptosis by targeting SOX9 in human colorectal cancer.
Insights
MicroRNA 133A (MIR133A) is downregulated in colorectal cancer (CRC). MIR133A targets SOX9, inhibiting CRC cell proliferation, migration, and tumor growth.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) play crucial roles in gene regulation and are implicated in various diseases, including cancer.
- Colorectal cancer (CRC) is a significant global health concern with complex molecular underpinnings.
- MIR133A has been identified as a potential tumor suppressor in several cancers, but its role in CRC requires further elucidation.
Purpose of the Study:
- To investigate the role of microRNA 133A (MIR133A) in human colorectal cancer (CRC).
- To identify direct target genes of MIR133A and elucidate the molecular mechanisms underlying its function in CRC.
- To evaluate the therapeutic potential of MIR133A in CRC models.
Main Methods:
- Bioinformatic prediction and transcriptome analysis to identify MIR133A target genes.
- Luciferase reporter assays, quantitative RT-PCR, and Western blot to validate SOX9 as a direct MIR133A target.
- In vitro studies using CRC cell lines with MIR133A overexpression or SOX9 knockdown.
- In vivo studies using a xenograft mouse model.
Main Results:
- MIR133A was found to be downregulated in human CRC tissues.
- SRY-box transcription factor 9 (SOX9) was identified and validated as a direct target of MIR133A.
- MIR133A overexpression suppressed CRC cell proliferation, colony formation, and migration by inhibiting SOX9 and its downstream signaling pathways (PIK3CA-AKT1-GSK3B-CTNNB1 and KRAS-BRAF-MAP2K1-MAPK1/3).
- MIR133A overexpression also increased apoptosis and suppressed tumor growth in a xenograft model.
Conclusions:
- MIR133A acts as a tumor suppressor in human colorectal cancer.
- The MIR133A-SOX9 axis is a key regulatory mechanism controlling CRC cell proliferation, migration, and apoptosis.
- MIR133A holds potential as a therapeutic agent for colorectal cancer.
Related Concept Videos
MicroRNAs
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

